ATE514426T1 - Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure - Google Patents

Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure

Info

Publication number
ATE514426T1
ATE514426T1 AT01972783T AT01972783T ATE514426T1 AT E514426 T1 ATE514426 T1 AT E514426T1 AT 01972783 T AT01972783 T AT 01972783T AT 01972783 T AT01972783 T AT 01972783T AT E514426 T1 ATE514426 T1 AT E514426T1
Authority
AT
Austria
Prior art keywords
formulations
reducing
environmental hormone
ursodesoxycholic acid
eliminating environmental
Prior art date
Application number
AT01972783T
Other languages
English (en)
Inventor
Jae-Duck Yeon
Kyong-Up Baik
Kyu-Hyuck Jung
Seung-Kook Park
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Application granted granted Critical
Publication of ATE514426T1 publication Critical patent/ATE514426T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01972783T 2000-10-04 2001-09-28 Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure ATE514426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0058127A KR100368936B1 (ko) 2000-10-04 2000-10-04 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제
PCT/KR2001/001643 WO2002028396A1 (en) 2000-10-04 2001-09-28 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid

Publications (1)

Publication Number Publication Date
ATE514426T1 true ATE514426T1 (de) 2011-07-15

Family

ID=19691665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972783T ATE514426T1 (de) 2000-10-04 2001-09-28 Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure

Country Status (9)

Country Link
US (1) US20040029965A1 (de)
EP (1) EP1322315B1 (de)
JP (1) JP3883506B2 (de)
KR (1) KR100368936B1 (de)
CN (1) CN1204892C (de)
AT (1) ATE514426T1 (de)
AU (1) AU2001292423A1 (de)
ES (1) ES2368992T3 (de)
WO (1) WO2002028396A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
KR100368936B1 (ko) * 2000-10-04 2003-01-24 주식회사 대웅 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제
KR20070084211A (ko) * 2004-10-15 2007-08-24 유서홍 약제학적 화합물의 독성을 감소시키기 위한 방법 및 조성물
CN119326070A (zh) * 2024-09-20 2025-01-21 怀化市农业科学研究院 一种微塑料中毒解毒剂及其在饲料中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
KR19990009411A (ko) * 1997-07-09 1999-02-05 이웅열 간장질환치료에 우수한 의약조성물
RU2224523C2 (ru) * 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
KR100293764B1 (ko) * 1998-08-10 2001-09-17 박명규 인삼을주성분으로하는다이옥신독성해독제
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
KR100340763B1 (ko) * 1999-09-21 2002-06-20 김권 남성 생식기능 저하에 대한 예방 및 치료효과를 지닌 천연페놀 및 폴리페놀계 화합물을 포함하는 약제학적 조성물
KR20010037134A (ko) * 1999-10-14 2001-05-07 김원규 우루소데옥시콜린산을 함유하는 액제 및 그 제조방법
KR100401456B1 (ko) * 1999-12-24 2003-10-11 (주) 한국신과학 기술센타 수컷의 생식 독성 억제에 유효한 펙틴을 포함한 약학 조성물
KR20010087593A (ko) * 2000-03-08 2001-09-21 김권 남성 생식기능 저하 예방 및 치료 효과를 지닌클로로제닉산을 주요 성분으로 하는 약제학적 조성물
KR100368936B1 (ko) * 2000-10-04 2003-01-24 주식회사 대웅 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제

Also Published As

Publication number Publication date
AU2001292423A1 (en) 2002-04-15
CN1468103A (zh) 2004-01-14
KR100368936B1 (ko) 2003-01-24
WO2002028396A1 (en) 2002-04-11
KR20020026999A (ko) 2002-04-13
EP1322315B1 (de) 2011-06-29
CN1204892C (zh) 2005-06-08
JP2004510739A (ja) 2004-04-08
EP1322315A1 (de) 2003-07-02
EP1322315A4 (de) 2004-05-26
JP3883506B2 (ja) 2007-02-21
US20040029965A1 (en) 2004-02-12
ES2368992T3 (es) 2011-11-24

Similar Documents

Publication Publication Date Title
IS6852A (is) Efnasambönd
AP2001002217A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids.
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR0012243A (pt) Triflúor butenos nematocidas
DE60109938D1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
ATE249214T1 (de) Pentafluorobenzensulfonamide und analoge
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
ES2188979T3 (es) Derivados de benzamidina sustituidos con derivados de aminoacidos ciclicos e hidroxiacidos ciclicos, y su uso como anti-coagulantes.
NO20022201L (no) Lösninger inneholdende Epinastin
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
IL172773A (en) Formulations for the treatment of arthritis conditions
MY114944A (en) Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use
SE9801494D0 (sv) Novel use
ATE514426T1 (de) Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure
ATE401901T1 (de) Antikrebs- und antivirale zusammensetzung
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
EE05318B1 (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hpogonadismi raviks
WO2001081328A3 (en) Thiazolidinedione analogues and their use for the treatment of diabetes
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
BR0009194A (pt) Composição do resorcinol
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties